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Abstract To answer the question as to whether pulmonary rehabilitation programs (PRP) induced increase in
exercise tolerance (ET) is associated with increased levels of exhaled nitric oxide (eNO) in COPD patients of di¡erent
degrees of severity, we designed a prospective and controlled study. Forty-seven stable COPD patients underwent
an 8-week outpatient multidisciplinary PRP including supervised incremental exercise. Fractional eNO concentration
(FENO) and peak work-rate (Wpeak) were assessed baseline (T1), at the end of 1-month run-in period (T0), and after
(T1) the PRP.Lung function, walking test, health-related qualityof life (HRQL) were also recorded.Patientswere divided
into three groups according to disease severity: 17 severe [FEV1 35 (5)% pred] COPD patients, seven of them with
cor pulmonale; 15 mild [FEV178 (6)% pred], and15 moderate [FEV156 (6)% pred] COPD patients.FENO did notdi¡er at
T-1 and T0 (mean absolute change (SD): 0.03 (0.09) 95% Cl-0.01, 0.16, 0.06 (1.03) 95% Cl 0.03, 0.75 and 0.05 (0.06) 95%
Cl 0.02, 0.11ppb inmild, moderate and severe patients, respectively). As compared toT0, bothWpeak (by17,15 and10%,
respectively) and FENO (by 29, 24 and16%, respectively) signi¢cantly increased in all groups, but not in patientswith cor
pulmonale. A signi¢cant correlation between pre- and post-PRP changes in Wpeak and FENO was found both in
mild to moderate (r=0.79, Po0.00001) and severe (r=0.76, Po0.001) COPD patients. After a PRP, improvement
in ET is associated with an increase in eNO also in most severe COPD patients, but not in those with cor pulmonale.
r 2002 Elsevier Science Ltd
doi:10.1053/rmed.2001.1286, available online at http://www.idealibrary.comon
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Exhaled nitric oxide (eNO) has been proposed as a non-
speci¢c bio-marker in animals and humans (1). Low eNO
levels have been reported in severe chronic obstructive
pulmonary disease (COPD) (2), especially in patients
with cor pulmonale (3).
In healthy subjects, eNO has been shown to be a mar-
kerofphysical ¢tness (4).Morerecently, pulmonaryreha-
bilitation program (PRP) related increase in exercise
tolerance (ET) was found to be associated to an increase
in eNO inmild-to-moderate COPD patients (5).
Bene¢ts of PRP have been reported in COPD patients
of di¡erent severity (6).We wondered whether changes
in eNO associatedwith increases in ETmight also be ob-
served in most severe COPD patients. Indeed, the re-Received 2 December 2001, accepted in revised form 20 December
2001.
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030 2521718; E-mail: nambrosino@fsm.itcent development of new therapeutical approaches such
as lung transplantation and lung volume reduction sur-
gery make severe COPD patients, even those with
chronic respiratory failure, candidates for rehabilitation
programs (7).
METHODS
The study was approved by the Ethical Committee
of Salvatore Maugeri Foundation IRCCS and patients
gave their informed consent to participate in the
study.
Patients
Forty-seven consecutive, male, stable COPD patients
(age 6777 years) referred to a multidisciplinary outpati-
ent PRP at the Pulmonary Rehabilitation unit of S. Mau-
geri Foundation, Scienti¢c Institute of Gussago, were
enrolled.They were divided into three groups according
to disease severity as de¢ned by the European Respira-
NITRIC OXIDE IN EXERCISED COPD PATIENTS 313tory Society (ERS) guidelines (8):mild [n=15,FEV178 (6)%
pred], moderate [n=15, FEV1 56 (6)% pred] and severe
[n=17, FEV135 (5)% pred]. All patients were ex-smokers
andnone of themhad anyhistoryof atopy. At the time of
the study, all of themwere clinically stable and were re-
ceiving their regular treatment with inhaled anticholi-
nergics and rescue short-term-b2-agonists but neither
systemic nor inhaled steroids. Seven out of17 patients in
the severe group were on long-term domiciliary oxygen
therapy and su¡ered from cor pulmonale as assessed by
echocardiography.
Assessment
The study was prospective and controlled, the patients
serving as controls of themselves. Measurements of
eNO and cycloergometry were performed at T-1, at the
end of a 1-month run-in period (T0), and after the
completion of PRP (T1). To further assess the clinical
e¡ects of PRP, the 6-min walking distance test (6MWD)
(9) and health-related quality of life by means of the
St.George Respiratory Questionnaire (SGRQ) (10) were
measured at T0 and T1. Data were collected by person-
nel not involved in the study. Furthermore, physicians
evaluating exercise tests were blind to eNO measure-
ments.
Lung function: Static and dynamic lung volumes were
measured by means of a constant volume body plethys-
mograph (Medical Graphic Corp. St. Paul, MN, U.S.A.)
with the patient in sitting position according to standard
procedure (11).
Exercise test: Symptom-limited incremental exercise
test was performed under EKG monitoring, on an
electrically braked cycloergometer (Ergometrics 800S,
Sensormedics, Yorba Linda, CA, U.S.A.) using the
standard 1-min incremental cycle exercise protocol
(10W each minute) as previously described (5). Mixed-
expired gas data, minute ventilation _VE, and breathing
pattern, were continuously monitored. At rest and
at 1-min intervals during exercise, patients were asked
their perceived dysponea (D) and sensation of leg
fatigue (F ) by pointing to a number or phrase on a
10-point Borg scale set in large type on a sheet in front
of them (12)..
ExhaledNO:Resting exhaledNOwas assessed on-line
bymeans of a chemiluminescence analyzer (LR 2000 ser-
ies, Logan Research, Rochester, U.K.) as recommended
and previously described (2,3,5,13). The mean value of
three reproducible (less than 5% within patient variabil-
ity) readings of eNO plateau (FENO) was considered.
Pulmonary Rehabilitation Program
The PRP was a multidisciplinary program consisting of
three 3-h sessions per week for 8^10 weeks, includingsupervised incremental exercise, abdominal, upper and
lower limb muscle activities, shoulder and full-arm cir-
cling, patient’s speci¢c education which has been de-
scribed elsewhere (5,14).
Statistical analysis
All data are shown as mean and standard deviation (SD)
or standard error (SE) as speci¢ed. One-way ANOVA
for repeated measures was used to test within patients
time course of results: post hoc test was then applied
when appropriate. Wilcoxon matched paired test was
added to test di¡erences for non-parametric measures.
Spearman analysis was then used to evaluate the linear
correlation coe⁄cient between FENO and other func-
tional parameters. A P value of less than 0.05was consid-
ered to be statistically signi¢cant.
RESULTS
Characteristics of patients in the study and results are
shown inTable1. As expected, baseline ETwas slightly in-
versely correlated with airway obstruction (FEV1 vs
Wpeak: r=0.37, P=0.009).No di¡erences in ETwas found
between T-1 and T0. After PRP,Wpeak signi¢cantly in-
creased by 17, 15 and 10% in mild, moderate and severe
patients, respectively, whereas the increase in 6MWD
was not signi¢cant. The lowest increase in Wpeak ob-
served in severe patients was mostly due to seven pa-
tients with cor pulmonale who did not show any change
in ET [from 61 (19) to 62 (24)Wat T0 and T1, respectively,
meanchange (SD):1.4 (6.9) 95%Cl1.9 8.1W], the other
10 severe COPD patients without cor pulmonale, show-
ing a mean14% increase inWpeak.
Compared withT-1 and T0, at T1D and F at the same
workload (iso-watts) were signi¢cantly reduced in all
groups. SGRQ (total score) signi¢cantly improved by 19,
15 and10% inmild,moderate and severepatients, respec-
tively (Table1).
Themeanvalues of FENOmeasured over time are also
shown in Table 1. Resting FENO assessed at T-1 and T0
were very similar (mean absolute change (SD): 0.03 (0.09)
95% Cl 0.01, 0.16, 0.06 (1.03) 95% Cl 0.03, 0.75 and 0.05
(0.06) 95% Cl 0.02 0.11ppb in mild, moderate and severe
patients, respectively). Baseline FENO was higher in mild
andmoderate than in severe patients. At T1FENO signi¢-
cantly increased by 29, 24 and16% inmild, moderate and
severe COPD, respectively (Table1).The lowest increase
in FENO observed in severe patients was due to seven
COPD patients with cor pulmonale [from 5.2 (0.9) to 5.7
(1.4) ppb at T0 and T1, respectively, mean change (SD):
0.5 (0.8) 95% Cl 0.06 0.91ppb]. The other 10 severe
TABLE 1. Demographic, anthropometric, physiological characteristics of patients and e¡ects of PRP.Data are given asmean and
(SE)
Mild (n=15) Moderate (n=15) Severe (n=17)
T-1 T0 T1 T-1 T0 T1 T-1 T0 T1
Age 69 67 66
(years) (5) (7) (8)
BMI 28 27 26
(3) (3) (3)
FEV1* 77 57 34
(% predicted) (6) (6) (7)
Wpeak
* 95 91 107w 83 82 94z 65 68 75z
(W) (18) (23) (29) (22) (19) (26) (22) (28) (36)
Diso-watt
* 7.3 7.7 6.0} 7.6 6.4 5.5} 8.3 8.0 6.1z
(score) (1.1) (1.9) (0.5) (2.0) (2.2) (0.7) (0.8) (1.3) (0.6)
Fiso-watt
* 7.7 7.5 6.1} 7.1 7.7 6.2} 8.5 7.9 6.7}
(score) (1.2) (1.5) (0.7) (1.5) (1.0) (0.8) (0.7) (1.2) (0.4)
6MWD 463 502 473 503 380 424
(m) (58) (65) (56) (59) (83) (105)
SQRQ 38 31} 39 33} 48 43}
(total) (14) (13) (14) (16) (15) (16)
FENO
* 7.3 7.7 10.0w 5.3 6.2 7.7w 5.5 5.7 6.6z
(ppb) (2.6) (2.3) (2.9) (3.1) (2.1) (2.3) (0.9) (1.4) (1.9)
*Anova Po0.05 betweengroups.
wPost hoc test Po0.005 (vsT0 and T-1)
zPost hoc test Po0.01 (vsT0 and T-1)
}Post hoc test Po0.05 (vsT0 and T-1)
Wpeak=peak workload, 6MWD=6min walking distance walk, SGRQ=St.George Respiratory Questionnaire,D= iso-load per-
ceived dispnoea by BORG scale, F= isoloadperceived leg-fatigue by BORGscale.
314 RESPIRATORYMEDICINEpatients without cor pulmonale showed a post-PRP
mean increase in FENO by 22%.
There was signi¢cant correlation between pre- and
post-PRP changes in Wpeak and in FENO in the whole
group (r=0.78, Po0.0001; Fig. 1Fpanel A) as well as in
the mild to moderate (r=0.79, Po0.00001; Fig. 1Fpanel
B) and severe (r=0.76,Po0.001; Fig.1Fpanel C) patients.
No signi¢cant relationship was observed between
changes in FENO and changes in 6MWD or SGRQ in any
group of patients.
DISCUSSION
This study shows that improvement in ET following an
outpatient PRP is associated to a parallel increase in rest-
ing eNO in COPD patients of di¡erent degrees of sever-
ity.This increase is also observed in COPD patients with
most severe airway obstruction, but not in those with
cor pulmonale.
This study con¢rms that PRP may induce bene¢ts
in ET of COPD patients independent of the degreeof severity (6). Nevertheless, severe patients with cor
pulmonale in our study did not show such positive
results.
In a previous study (5), after a multidisciplinary PRP,
mild-to-moderate COPD outpatients showed an in-
crease in eNO correlated with the improvement in ET,
thus suggesting FENO as a marker of physical ¢tness (15).
This study extends those results (5) to severe COPD pa-
tients without cor pulmonale.The highly signi¢cant cor-
relation between pre- and post-PRP changes in Wpeak
and in FENO was independent of airway obstruction
(see Fig. 1). An indirect evidence of the relationship
between ETand FENO is also given by the fact that pa-
tients with cor pulmonale neither gained any bene¢t
from PRP, nor showed any increase in eNO (Fig.1, open
triangles).
Di¡erent fromWpeak, no signi¢cant relationship was
observed between post-PRP changes in FENO and
6MWD.This re£ects di¡erences in the modalities of ex-
ercise tests, the 6MWD being more related to the en-
durance capacity than the incremental test. The lack of
relationship between changes in eNO and in HRQL is
not surprising, probably re£ecting the comprehensive
Fig. 1. Correlationsbetweenpost-PRPpercentage changesin FENOandinpeakworkload (Wpeak) in all (r=0.78;Po0.0001, panel A)
mild to moderate (r=0.79 Po0.00001, panel B) and severe (r=0.76 in severe; Po0.001, panel C) COPD patients.Open triangles =
patientswith cor pulmonale.
NITRIC OXIDE IN EXERCISED COPD PATIENTS 315nature of the PRP and the fact that HRQL depends on
more than just exercise ability (14).
In conclusion, this study answered the initial question
in that post-PRP improvement in ET is associated to
changes in eNO in most severe COPD patients, but not
in those with cor pulmonale.What is the relative role of
eNO and physical conditioning in these patientsmust be
elucidated by further studies.
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